SCHEMBL24470403

SCHEMBL24470403

CS(=O)(=O)CCc1ccc(C(=O)O)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.55
POLB P06746 7/20 0.51
ALDH1A1 P00352 2/20 0.51
ESR1 P03372 1/20 0.51
NR4A1 P22736 1/20 0.51
APEX1 P27695 1/20 0.51
RECQL P46063 1/20 0.51
DUSP3 P51452 1/20 0.51
PTPN5 P54829 1/20 0.51
PTPN11 Q06124 1/20 0.51
ESR2 Q92731 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
KMT2A Q03164 3/20 0.47
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 2/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26227623 0.83 TDP1 (0.55) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL26231726 0.82 POLB (0.62) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL24470412 0.82 HTT (0.63) POLBALDH1A1KMT2ANPC1RAB9A
SCHEMBL3823765 0.79 LTA4H (0.47) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL13841169 0.78 TDP1 (0.62) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL27313148 0.76 TDP1 (0.70) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL13379467 0.75 TDP1 (0.58) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL6364915 0.75 TDP1 (0.58) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL28943331 0.75 NPC1 (0.55) TDP1POLBALDH1A1ESR1NR4A1
SCHEMBL17537931 0.74 TDP1 (0.62) TDP1POLBALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251621-A1 AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 EP disclosed
US-20230286969-A1 AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2023-09-14 US disclosed
US-20230286969-A1 AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2023-09-14 US disclosed
CN-116390920-A Aromatic spirocyclic amide derivatives for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-07-04 CN disclosed
WO-2022112207-A1 AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 WO disclosed
WO-2022112207-A1 AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286969-A1 AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HAVCR2, NR1H4, SLC10A1 TDP1 4377/4885POLB 3791/4885ALDH1A1 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.